:: pharmac, manufacturing News |
Jubilant Organosys offers US$255 million to buy Draxis Health - 940 News
With this acquisition Jubilant will become one of the leading providers of contract manufacturing of small volume parenterals to largepharmaceuticalsand[...]
|
Indevus Rises on European Vantas License - Houston Chronicle
2008 AP NEW YORKâ IndevusPharmaceuticalsshares are rising after the company licensed its prostate cancer implant Vantas to a Europeanpharmaceutical[...]
|
Auto sector leads Tokyo lower - Investment Markets
Also seeing declines were airlines, retailers, and the oil andpharmaceuticalssectors. Markets were mixed in London, where the FTSE 100 added 0.95 percent[...]
|
UPDATE 1-Atrium Innovations to sell active ingredients unit - Reuters
TORONTO, April 4 (Reuters) - Canadianpharmaceuticalscompany Atrium Innovations (ATB.TO: Quote, Profile, Research) said on Friday it plans to sell its[...]
|
Avalon Pharma Receives Audit Opinion Containing Going Concern ... - RTT News
4/4/2008 2:08:16 PM AvalonPharmaceuticalsInc. (AVRX) announced that the independent audit report included in the Company's Annual Report on Form 10-K for[...]
|
Avalon Pharmaceuticals Receives Audit Opinion Containing Going ... - PharmaLive.com (press release)
GERMANTOWN, Md.--(BUSINESS WIRE)--Apr 4, 2008 - AvalonPharmaceuticals, Inc. (Nasdaq:AVRX), today announced, in compliance with NASDAQ Marketplace Rule[...]
|
Jubilant Organosys offers US$255 million to buy Draxis Health - Canada East
With this acquisition Jubilant will become one of the leading providers of contract manufacturing of small volume parenterals to largepharmaceuticalsand[...]
|
Jubilant Organosys offers US$255 million to buy Draxis Health - CFTKTV
With this acquisition Jubilant will become one of the leading providers of contract manufacturing of small volume parenterals to largepharmaceuticalsand[...]
|
Indevus Rises on European Vantas License - CNNMoney.com
NEW YORK (Associated Press) - IndevusPharmaceuticalsshares are rising after the company licensed its prostate cancer implant Vantas to a European[...]
|
Indevus rises on European Vantas license - MSN Money
NEW YORK (AP) - IndevusPharmaceuticalsshares are rising after the company licensed its prostate cancer implant Vantas to a Europeanpharmaceuticalcompany[...]
|
| [<<]
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
[>>]
|
